34 related articles for article (PubMed ID: 36017739)
1. Effect of tumor-infiltrating immune cells (mast cells, neutrophils and lymphocytes) on neoadjuvant chemotherapy response in breast carcinomas.
Okcu O; Öztürk Ç; Yalçın N; Yalçın AC; Şen B; Aydın E; Öztürk AE
Ann Diagn Pathol; 2024 Jun; 70():152301. PubMed ID: 38581761
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes and breast cancer mortality in racially and ethnically diverse participants of the Northern California Breast Cancer Family Registry.
Ransohoff JD; Miller I; Koo J; Joshi V; Kurian AW; Allison KH; John EM; Telli ML
JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38547391
[TBL] [Abstract][Full Text] [Related]
3. Assessment of stromal tumor-infiltrating lymphocytes in neoadjuvant chemotherapy for invasive breast carcinoma: Predictive insights across molecular subtypes.
Khan AA; Ahuja S; Kiruthikasri K; Zaheer S
Pathol Res Pract; 2024 May; 260():155382. PubMed ID: 38850879
[TBL] [Abstract][Full Text] [Related]
4. Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer.
Griguolo G; Serna G; Pascual T; Fasani R; Guardia X; Chic N; Paré L; Pernas S; Muñoz M; Oliveira M; Vidal M; Llombart-Cussac A; Cortés J; Galván P; Bermejo B; Martínez N; López R; Morales S; Garau I; Manso L; Alarcón J; Martínez E; Villagrasa P; Prat A; Nuciforo P
NPJ Precis Oncol; 2021 Mar; 5(1):23. PubMed ID: 33742063
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Assessment of Tumor-Infiltrating Lymphocytes in Primary Breast Cancer Following Neoadjuvant Radiation Therapy.
Yoneyama M; Zormpas-Petridis K; Robinson R; Sobhani F; Provenzano E; Steel H; Lightowlers S; Towns C; Castillo SP; Anbalagan S; Lund T; Wennerberg E; Melcher A; Coles CE; Roxanis I; Yuan Y; Somaiah N
Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38677525
[TBL] [Abstract][Full Text] [Related]
6. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Kos Z; Roblin E; Kim RS; Michiels S; Gallas BD; Chen W; van de Vijver KK; Goel S; Adams S; Demaria S; Viale G; Nielsen TO; Badve SS; Symmans WF; Sotiriou C; Rimm DL; Hewitt S; Denkert C; Loibl S; Luen SJ; Bartlett JMS; Savas P; Pruneri G; Dillon DA; Cheang MCU; Tutt A; Hall JA; Kok M; Horlings HM; Madabhushi A; van der Laak J; Ciompi F; Laenkholm AV; Bellolio E; Gruosso T; Fox SB; Araya JC; Floris G; Hudeček J; Voorwerk L; Beck AH; Kerner J; Larsimont D; Declercq S; Van den Eynden G; Pusztai L; Ehinger A; Yang W; AbdulJabbar K; Yuan Y; Singh R; Hiley C; Bakir MA; Lazar AJ; Naber S; Wienert S; Castillo M; Curigliano G; Dieci MV; André F; Swanton C; Reis-Filho J; Sparano J; Balslev E; Chen IC; Stovgaard EIS; Pogue-Geile K; Blenman KRM; Penault-Llorca F; Schnitt S; Lakhani SR; Vincent-Salomon A; Rojo F; Braybrooke JP; Hanna MG; Soler-Monsó MT; Bethmann D; Castaneda CA; Willard-Gallo K; Sharma A; Lien HC; Fineberg S; Thagaard J; Comerma L; Gonzalez-Ericsson P; Brogi E; Loi S; Saltz J; Klaushen F; Cooper L; Amgad M; Moore DA; Salgado R;
NPJ Breast Cancer; 2020; 6():17. PubMed ID: 32411819
[TBL] [Abstract][Full Text] [Related]
7. Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy.
Pascual T; Fernandez-Martinez A; Agrawal Y; Pfefferle AD; Chic N; Brasó-Maristany F; Gonzàlez-Farré B; Paré L; Villacampa G; Saura C; Hernando C; Muñoz M; Galván P; Gonzàlez-Farré X; Oliveira M; Gil-Gil M; Ciruelos E; Villagrasa P; Gavilá J; Prat A; Perou CM
NPJ Breast Cancer; 2024 Mar; 10(1):20. PubMed ID: 38448600
[TBL] [Abstract][Full Text] [Related]
8. Joint Region and Nucleus Segmentation for Characterization of Tumor Infiltrating Lymphocytes in Breast Cancer.
Amgad M; Sarkar A; Srinivas C; Redman R; Ratra S; Bechert CJ; Calhoun BC; Mrazeck K; Kurkure U; Cooper LA; Barnes M
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10956():. PubMed ID: 31997849
[TBL] [Abstract][Full Text] [Related]
9. Bibliometric analysis and visualization of endocrine therapy for breast cancer research in the last two decade.
Wang D; Yang Y; Yang L; Yang H
Front Endocrinol (Lausanne); 2023; 14():1287101. PubMed ID: 38116321
[TBL] [Abstract][Full Text] [Related]
10. A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients.
Hwang HW; Jung H; Hyeon J; Park YH; Ahn JS; Im YH; Nam SJ; Kim SW; Lee JE; Yu JH; Lee SK; Choi M; Cho SY; Cho EY
Breast Cancer Res Treat; 2019 Jan; 173(2):255-266. PubMed ID: 30324273
[TBL] [Abstract][Full Text] [Related]
11. The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
Mao Y; Qu Q; Zhang Y; Liu J; Chen X; Shen K
PLoS One; 2014; 9(12):e115103. PubMed ID: 25501357
[TBL] [Abstract][Full Text] [Related]
12. The effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes in patients with breast cancer.
Ilgun AS; Aktepe F; Gonullu O; Kapucuoglu N; Yararbas K; Alco G; Ozturk A; Elbuken Celebi F; Erdogan Z; Ordu C; Unal C; Duymaz T; Soybir G; Yavuz E; Tuzlali S; Ozmen V
Future Oncol; 2022 Sep; 18(29):3289-3298. PubMed ID: 36017739
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
Yang X; Rao J; Yang W; Shui R
Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
[TBL] [Abstract][Full Text] [Related]
14. Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
Kolberg-Liedtke C; Feuerhake F; Garke M; Christgen M; Kates R; Grischke EM; Forstbauer H; Braun M; Warm M; Hackmann J; Uleer C; Aktas B; Schumacher C; Kuemmel S; Wuerstlein R; Graeser M; Nitz U; Kreipe H; Gluz O; Harbeck N
Breast Cancer Res; 2022 Sep; 24(1):58. PubMed ID: 36056374
[TBL] [Abstract][Full Text] [Related]
15. BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Candelaria RP; Spak DA; Rauch GM; Huo L; Bassett RL; Santiago L; Scoggins ME; Guirguis MS; Patel MM; Whitman GJ; Moulder SL; Thompson AM; Ravenberg EE; White JB; Abuhadra NK; Valero V; Litton J; Adrada BE; Yang WT
Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S35-S41. PubMed ID: 34272161
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
